Andrea Comba

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Top Venues

Expert opinion on biological therapy

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Syed Mohd Faisal, Jarred E Clewner, Brooklyn Stack, Maria L Varela, Andrea Comba, Grace Abbud, Sebastien Motsch, Maria G Castro, Pedro R Lowenstein
Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Syed Mohd Faisal, Jarred E Clewner, Brooklyn Stack, Maria L Varela, Andrea Comba, Grace Abbud, Sebastien Motsch, Maria G Castro, Pedro R Lowenstein
Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (18) (2024)
Syed Mohd Faisal, Jarred E Clewner, Brooklyn Stack, Maria L Varela, Andrea Comba, Grace Abbud, Sebastien Motsch, Maria G Castro, Pedro R Lowenstein
Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (18) (2024)
Syed Mohd Faisal, Jarred E Clewner, Brooklyn Stack, Maria L Varela, Andrea Comba, Grace Abbud, Sebastien Motsch, Maria G Castro, Pedro R Lowenstein
Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (18) (2024)
Kevin B Wood, Andrea Comba, Sebastien Motsch, Tomas S Grigera, Pedro R Lowenstein
Scale-free correlations and potential criticality in weakly ordered populations of brain cancer cells. Science advances 9 (26) (2023)
Maria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, Brandon McClellan, Ziwen Zhu, Anzar Mujeeb, Yingxiang Li, Jin Yu, Padma Kadiyala, Ayman Taher, Felipe J Núñez, Mahmoud S Alghamri, Andrea Comba, Flor M Mendez, Alejandro J Nicola Candia, Brittany Salazar, Carl Koschmann, Fernando M Nunez, Marta Edwards, Tingting Qin, Maureen A Sartor, Pedro R Lowenstein, Maria Graciela Castro
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas. bioRxiv : the preprint server for biology (2023)
Kevin B Wood, Andrea Comba, Sebastien Motsch, Tomas S Grigera, Pedro R Lowenstein
Scale-free correlations and potential criticality in weakly ordered populations of brain cancer cells. Science advances 9 (26) (2023)
Kevin B Wood, Andrea Comba, Sebastien Motsch, Tomas S Grigera, Pedro R Lowenstein
Scale-free correlations and potential criticality in weakly ordered populations of brain cancer cells. Science advances 9 (26) (2023)
María Luisa Varela, Andrea Comba, Syed Mohd Faisal, Anna Argento, Andrea Franson, Marcus N Barissi, Sean Sachdev, Maria Graciela Castro, Pedro R Lowenstein
Gene Therapy for High Grade Glioma: The Clinical Experience. Expert opinion on biological therapy 23 (2) (2022)
María Luisa Varela, Andrea Comba, Syed Mohd Faisal, Anna Argento, Andrea Franson, Marcus N Barissi, Sean Sachdev, Maria Graciela Castro, Pedro R Lowenstein
Gene Therapy for High Grade Glioma: The Clinical Experience. Expert opinion on biological therapy 23 (2) (2022)
Maria Luisa Varela, Andrea Comba, Syed Mohd Faisal, Anna Argento, Andrea Franson, Marcus N Barissi, Sean Sachdev, Maria Graciela Castro, Pedro R Lowenstein
Gene therapy for high grade glioma: the clinical experience. Expert opinion on biological therapy (2022)
María Luisa Varela, Andrea Comba, Syed Mohd Faisal, Anna Argento, Andrea Franson, Marcus N Barissi, Sean Sachdev, Maria Graciela Castro, Pedro R Lowenstein
Gene Therapy for High Grade Glioma: The Clinical Experience. Expert opinion on biological therapy 23 (2) (2022)
Andrea Comba, Syed Mohd Faisal, Patrick J Dunn, Anna E Argento, Todd C Hollon, Wajd N Al-Holou, María Luisa Varela, Daniel B Zamler, Gunnar L Quass, Pierre F Apostolides, Clifford Abel, Christine E Brown, Phillip E Kish, Alon Kahana, Celina G Kleer, Sebastien Motsch, Maria Graciela Castro, Pedro R Lowenstein
Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression. Nature communications 13 (1) (2022)
María Luisa Varela, Andrea Comba, Syed Mohd Faisal, Anna Argento, Andrea Franson, Marcus N Barissi, Sean Sachdev, Maria Graciela Castro, Pedro R Lowenstein
Gene Therapy for High Grade Glioma: The Clinical Experience. Expert opinion on biological therapy 23 (2) (2022)
María Luisa Varela, Andrea Comba, Syed Mohd Faisal, Anna Argento, Andrea Franson, Marcus N Barissi, Sean Sachdev, Maria Graciela Castro, Pedro R Lowenstein
Gene Therapy for High Grade Glioma: The Clinical Experience. Expert opinion on biological therapy 23 (2) (2022)
María Luisa Varela, Andrea Comba, Syed Mohd Faisal, Anna Argento, Andrea Franson, Marcus N Barissi, Sean Sachdev, Maria Graciela Castro, Pedro R Lowenstein
Gene Therapy for High Grade Glioma: The Clinical Experience. Expert opinion on biological therapy 23 (2) (2022)
Diana Shah, Andrea Comba, Syed Mohd Faisal, Padma Kadiyala, Gregory J Baker, Mahmoud S Alghamri, Robert Doherty, Daniel B Zamler, Gabriel Nuñez, Maria Graciela Castro, Pedro R Lowenstein
A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1. Oncoimmunology 10 (1) (2021)
Sara Jamous, Andrea Comba, Pedro R Lowenstein, Sebastien Motsch
Self-organization in brain tumors: How cell morphology and cell density influence glioma pattern formation. PLoS computational biology 16 (5) (2020)
María Belén Garcia-Fabiani, Maria Ventosa, Andrea Comba, Marianela Candolfi, Alejandro Javier Nicola Candia, Mahmoud S Alghamri, Padma Kadiyala, Stephen V Carney, Syed M Faisal, Anna A Schwendeman, James J Moon, Lindsay M Scheetz, Joerg Lahann, Ava Mauser, Pedro R Lowenstein, Maria Graciela Castro
Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development. Expert opinion on investigational drugs 29 (7) (2020)